Royal Bank Of Canada Volitionrx LTD Transaction History

Royal Bank Of Canada

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.59 - $0.91 $24 - $38	42 Added 102.44%	83 $0
Q1 2024 Nov 05, 2024	SELL	$0.72 - $1.19 $30 - $49	-42 Reduced 50.6%	41 $0
Q1 2024 May 15, 2024	SELL	$0.72 - $1.19 $301 - $498	-419 Reduced 91.09%	41 $0
Q4 2023 Feb 14, 2024	BUY	$0.55 - $0.88 $253 - $404	460 New	460 $0
Q2 2023 Aug 14, 2023	BUY	$1.39 - $2.02 $564 - $820	406 New	406 $0
Q3 2022 Nov 14, 2022	BUY	$1.36 - $2.38 $252 - $442	186 New	186 $0
Q2 2022 Aug 15, 2022	SELL	$1.96 - $3.05 $47 - $73	-24 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.41 - $3.24 $45 - $61	19 Added 380.0%	24 $0
Q4 2021 Feb 14, 2022	SELL	$3.02 - $4.13 $78 - $107	-26 Reduced 83.87%	5 $0
Q3 2021 Nov 15, 2021	SELL	$2.98 - $3.48 $4,091 - $4,778	-1,373 Reduced 97.79%	31 $0
Q2 2021 Aug 16, 2021	BUY	$3.01 - $3.78 $4,226 - $5,307	1,404 New	1,404 $5,000

17.8M

41K

100

Ticker VNRX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 57,297,000
Market Cap $39M
Description
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.